Cancers in distant organs alter liver function

Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions, according to a study from investigators at Weill Cornell Medicine.

Grant funds study of cannabis effects on HIV-infected brain tissue

Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.

Celebrating Weill Cornell’s newest graduates at Commencement

380 graduates in the Class of 2023 received their degrees from Weill Cornell Medicine during the institution’s annual commencement ceremony at Carnegie Hall on May 18.

Medical school, minus the debt

Weill Cornell Medicine’s debt-reduction program was created in 2019 to cover tuition, fees, housing and living expenses for students with financial need.

Around Cornell

Long COVID risk and symptoms vary across populations

A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment.

Tobias Meyer elected to the American Academy of Arts and Sciences

Meyer is the Joseph C. Hinsey Professor in Cell and Developmental Biology at Weill Cornell Medicine.

HIV patients fare well with mpox treatment

Patients with HIV had similar treatment outcomes to patients without HIV when treated for mpox with an antiviral drug called tecovirimat, according to a new study.

Engineering, Weill Cornell Medicine pilot M.D.-M.Eng. degree

As part of a new cross-college initiative designed to accelerate engineering innovations in medicine, Cornell Engineering is piloting an M.D.-M.Eng. program that allows medical students at Weill Cornell Medicine to earn a one-year professional Master of Engineering degree.

Around Cornell

Epigenetic drug aids chemotherapy in lymphoma study

Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.